Our leadership team works relentlessly to ensure we uphold our commitment to creating effective products that make a difference in healthcare. Meet the team who continues to lead us towards growth and success as we continue to develop innovative products.



Anish Bhatnagar, MD
Chief Executive Officer

Dr. Bhatnagar was appointed as our Chief Executive Officer in February 2014. Prior to that, he served as our President and Chief Operating Officer. Dr. Bhatnagar joined us in 2006, and has held positions of increasing responsibility since then. Dr. Bhatnagar is a physician with over 15 years of experience in the medical device and biopharmaceutical industries. His experience spans development of biologics, drugs, drug-device combinations and diagnostic as well as therapeutic medical devices. His prior experience includes working at Coulter Pharmaceuticals, Inc. from 1998 to 2000 and Titan Pharmaceuticals, Inc. from 2000 to 2006. He is the author of several peer-reviewed publications, abstracts and book chapters. He obtained his medical degree at SMS Medical College in Jaipur, India and completed his Residency and Fellowship training in the U.S. at various institutions, including Georgetown University Hospital and the University of Pennsylvania.


David O’Toole
Chief Financial Officer

Mr. O’Toole was appointed Chief Financial Officer in July 2014. He has more than 30 years of experience in the accounting and finance sectors, and for the past 14 years has focused on the medical device, tools, and diagnostics industry. From September 2012 to June 2014, Mr. O’Toole was Senior Vice President and Chief Financial Officer at Codexis, Inc., a public company focused on developing biocatalysts. From May 2010 to August 2012, Mr. O’Toole was Vice President and Chief Financial Officer at Response Genetics, Inc., and served from May 2008 to August 2010 as Executive Vice President and Chief Financial Officer of Abraxis Bioscience, Inc. From 1992 to 2008, Mr. O’Toole worked at Deloitte & Touche LLP, where he served for 12 of those years as a partner. He worked at Arthur Anderson & Co. from 1984 to 1992 as an international tax manager. Mr. O’Toole received his Bachelor of Science degree in accounting from the University of Arizona, and is a certified public accountant.



Anthony “Tony” Wondka
Vice President, Research and Development

Mr. Wondka was appointed Vice President of Research at Capnia, a subsidiary of Soleno, in June 2013, after working as a consultant for the company since May 2001. He has held management and executive positions in the medical device industry for over 20 years in large and small companies. From April 2006 to March 2011, Mr. Wondka served as Vice President of R&D, and Vice President of Technology and Clinical Affairs for Breathe Technologies, where he invented and co-invented ventilation products that address large unmet needs in chronic obstructive pulmonary disease (COPD), and obstructive sleep apnea. From July 1997 to April 2006, Mr. Wondka was Director of R&D and Vice President of Manufacturing at Pulmonx, where he co-invented and led the early development of the Chartis™ diagnostic system and procedure that is used to guide endobronchial lung volume reduction for the treatment of COPD, which is currently being sold in the E.U. Prior to Pulmonx, Mr. Wondka worked at Pfizer subsidiary Shiley (acquired by Covidien) and Bear Medical (acquired by Carefusion), where he held lead roles in engineering and quality assurance, supporting commercialization activities for market leading ENT and respiratory products. He holds over 40 issued or pending patents, and has a Bachelor of Science degree bioengineering from the University of California, San Diego.